Laboratoire d'Innovation Moléculaire et Applications (LIMA), Team Bio(IN)organic & Medicinal Chemistry, UMR7042 CNRS-Université de Strasbourg-Université Haute-Alsace, European School of Chemistry, Polymers and Materials (ECPM), 25, Rue Becquerel, F-67087 Strasbourg, France.
Swiss Tropical and Public Health Institute, Kreuzstrasse 2, CH-4123 Allschwil, Switzerland.
Molecules. 2024 Nov 7;29(22):5268. doi: 10.3390/molecules29225268.
Ψ-1,4-naphthoquinones (Ψ-NQ) are non-quinoid compounds in which aromaticity-found in 1,4-naphthoquinones-is broken by the introduction of an angular methyl at C-4a or -8a. This series was designed to act as prodrugs of 1,4-naphthoquinones in an oxidative environment. Furthermore, from a medicinal chemistry point of view, the loss of planarity of the scaffold might lead to an improved solubility and circumvent the bad reputation of quinones in the pharmaceutical industry. In this work, we illustrated the concept by the synthesis of Ψ -plasmodione regioisomers as prodrugs of the antimalarial plasmodione. The presence of a chiral center introduces a new degree of freedom to be controlled by enantioselectivity and regioselectivity of the cycloaddition in the Diels-Alder reaction. The first strategy that was followed was based on the use of a chiral enantiopure sulfoxide to govern the stereoselective formation of (+)Ψ-NQ or (-)Ψ-NQ, depending on the chirality of the sulfoxide ( or ). New sulfinylquinones were synthesized but were found to be ineffective in undergoing cycloaddition with different dienes under a wide range of conditions (thermal, Lewis acid). The second strategy was based on the use of boronic acid-substituted benzoquinones as auxiliaries to control the regioselectivity. Using this methodology to prepare the (±)Ψ-NQ racemates, promising results (very fast cycloaddition time: ~2 h) were obtained with boronic acid-based quinones and in the presence of 1-methoxy-1,3-butadiene, to generate the 4a- and the 8a-Ψ-plasmodione regioisomers and (synthesized in six steps with a total yield of 10.5% and 4.1%, respectively. As the expected prodrug effect can only be revealed if the molecule undergoes an oxidation of the angular methyl, e.g., in blood-feeding parasites that digest hemoglobin from the host, the antimalarial and the antischistosomal properties of both (±)Ψ-NQ regioisomers were determined in drug assays with and . Metabolic studies under quasi-physiological conditions and LC-MS analyses were undertaken to reveal the generation of plasmodione from both the 4a- and the 8a-Ψ-plasmodione regioisomers.
Ψ-1,4-萘醌(Ψ-NQ)是非醌类化合物,其芳香性存在于 1,4-萘醌中,通过在 C-4a 或 C-8a 处引入角甲基而被打破。该系列旨在作为氧化环境中 1,4-萘醌的前药。此外,从药物化学的角度来看,支架的平面性丧失可能导致溶解度提高,并避免醌类药物在制药行业的不良声誉。在这项工作中,我们通过合成 Ψ-疟原虫酮的区域异构体作为抗疟药疟原虫酮的前药来说明了这一概念。手性中心的存在引入了一个新的自由度,可以通过 Diels-Alder 反应中环加成的对映选择性和区域选择性来控制。遵循的第一个策略是基于使用手性对映纯亚砜来控制 (+)Ψ-NQ 或 (-)Ψ-NQ 的立体选择性形成,这取决于亚砜的手性(或)。合成了新的亚磺酰基醌,但发现它们在广泛的条件(热、路易斯酸)下与不同的二烯进行环加成时无效。第二个策略是基于使用硼酸取代的苯醌作为辅助剂来控制区域选择性。使用这种方法制备(±)Ψ-NQ 外消旋体,用硼酸基醌和在 1-甲氧基-1,3-丁二烯的存在下,得到了 4a-和 8a-Ψ-疟原虫酮区域异构体和(分别以 10.5%和 4.1%的总收率合成了六步)。由于只有在前药分子发生角甲基氧化时才能显示出预期的前药效应,例如在消化宿主血红蛋白的食血寄生虫中,因此用和测定了两种(±)Ψ-NQ 区域异构体的抗疟和抗血吸虫病活性。在药物测定中进行了准生理条件下的代谢研究和 LC-MS 分析,以揭示两种 4a-和 8a-Ψ-疟原虫酮区域异构体从产生疟原虫酮。